AGL 40.00 No Change ▼ 0.00 (0%)
AIRLINK 127.04 No Change ▼ 0.00 (0%)
BOP 6.67 No Change ▼ 0.00 (0%)
CNERGY 4.51 No Change ▼ 0.00 (0%)
DCL 8.55 No Change ▼ 0.00 (0%)
DFML 41.44 No Change ▼ 0.00 (0%)
DGKC 86.85 No Change ▼ 0.00 (0%)
FCCL 32.28 No Change ▼ 0.00 (0%)
FFBL 64.80 No Change ▼ 0.00 (0%)
FFL 10.25 No Change ▼ 0.00 (0%)
HUBC 109.57 No Change ▼ 0.00 (0%)
HUMNL 14.68 No Change ▼ 0.00 (0%)
KEL 5.05 No Change ▼ 0.00 (0%)
KOSM 7.46 No Change ▼ 0.00 (0%)
MLCF 41.38 No Change ▼ 0.00 (0%)
NBP 60.41 No Change ▼ 0.00 (0%)
OGDC 190.10 No Change ▼ 0.00 (0%)
PAEL 27.83 No Change ▼ 0.00 (0%)
PIBTL 7.83 No Change ▼ 0.00 (0%)
PPL 150.06 No Change ▼ 0.00 (0%)
PRL 26.88 No Change ▼ 0.00 (0%)
PTC 16.07 No Change ▼ 0.00 (0%)
SEARL 86.00 No Change ▼ 0.00 (0%)
TELE 7.71 No Change ▼ 0.00 (0%)
TOMCL 35.41 No Change ▼ 0.00 (0%)
TPLP 8.12 No Change ▼ 0.00 (0%)
TREET 16.41 No Change ▼ 0.00 (0%)
TRG 53.29 No Change ▼ 0.00 (0%)
UNITY 26.16 No Change ▼ 0.00 (0%)
WTL 1.26 No Change ▼ 0.00 (0%)
BR100 9,969 Increased By 85.1 (0.86%)
BR30 31,013 Increased By 412.7 (1.35%)
KSE100 94,097 Increased By 741.3 (0.79%)
KSE30 29,156 Increased By 225.2 (0.78%)
Pakistan

China's CanSinoBIO COVID-19 vaccine approved for emergency use in Pakistan

  • The approval was granted by the authority’s registration board on Friday.
  • Pakistan is the second country to approve use of China’s vaccine after Mexico.
Published February 12, 2021

The Drug Regulatory Authority of Pakistan (DRAP) has approved the emergency use of Chinese coronavirus (COVID-19) vaccine from CanSino Biologics.

As per details, the approval was granted by the authority’s registration board on Friday.

A request for the approval of the drug for emergency use was submitted to DRAP's registration board by AJM Pharma (Pvt) Limited, the report said.

The decision to approve it was taken during the third meeting of the authority's registration board.

Pakistan is the second country to approve use of China’s vaccine after Mexico.

Clinical trials for CanSinoBIO's vaccine were already going on in several countries, including Pakistan.

Comments

Comments are closed.